Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive